Wish List for early-stage partnering
Immuno-sciences (Treg, Microglia/ Macrophage, Innate Lymphoid Cells)
In Vivo Reprogramming
Targeted Protein Degrader
Engineered antibodies/ bi-specifics
In Vivo Cell Engineering
Our Focus Area Approach
Astellas has established a Focus Area Approach for its research and development strategy. Specifically, our Focus Area Strategy is defined as combinations of three components: (1) biologies with high disease relevance, (2) versatile modalities/technologies, and (3) diseases with high unmet medical needs that are expected to be tackled by the first two components. We view this strategy as a way to build a sustainable, expandable drug discovery approach to develop new platforms, leverage expertise and create innovative products.
The Focus Areas are constantly adapting in response to advances in science and changes in disease treatment paradigms.